Independent Medical Education

Oncology: Precision Medicine And Diagnostics

Lilly is committed to supporting high-quality education and QI initiatives that provide healthcare professionals (HCPs) with evidence-based, clinically relevant content that advances learners’ knowledge, competence, and performance in order to ultimately impact patient care. We believe quality education is an excellent source to accelerate evidence into practice for the best interest of HCPs and patients. This site shows independent accredited educational activities supported by Lilly via educational grants and targeted for HCPs. All accredited programs must follow the standards set forth in the ACCME Standards for Integrity and Independence in Accredited Continuing Education. All decisions related to the planning, faculty selection, content creation and delivery of accredited education are the sole responsibility of the providers and/or accreditors. Lilly does not support independent education, or any medical activities, for the purpose of encouraging off-label use of our products.

Because the ACCME Standards prohibit us from providing a direct link to the educational activity, you may have to search within the link using the title of the program.

Making the Right Call: Biomarker Testing and Targeting in NSCLC: Part I: Equitable, Guideline-based Testing for Prognosis and Treatment

On-Demand Webinar Activity

Provider: Medical Learning Institute, Inc.

Virtual Enduring
29-NOV-2022 to 31-MAR-2024

Making the Right Call: Biomarker Testing and Targeting in NSCLC: Part II: Treating Acquired Resistance and Evaluating Next-generation Therapies

On-Demand Webinar Activity

Provider: Medical Learning Institute, Inc.

Virtual Enduring
29-NOV-2022 to 31-MAR-2024

Oncology Consultations™: Addressing Clinical Gaps in Thyroid Cancer Management: Taking Action with Precision Methods to Personalize Treatment Decision-Making

On-Demand Discussion Activity

Provider: Physicians' Education Resource LLC

Virtual Enduring
23-DEC-2022 to 23-DEC-2023